Allele Biotechnology and Pharmaceuticals Inc., of San Diego, is partnering with Scientist.com to develop nanoantibodies for therapeutic applications. Allele's recombinant, fully humanized, camelid single-domain heavy-chain only antibodies can be linked to produce multivalent new molecular entities.